Raynham, MA, United States of America

Kyle A Totaro

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Brown University. Active years: 2015-2020.

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • East Providence, RI (US) (2015)
  • Raynham, MA (US) (2020)

Company Filing History:


Years Active: 2015-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Kyle A. Totaro

Introduction

Kyle A. Totaro is an accomplished inventor based in Raynham, MA (US). He has made significant contributions to the field of science and technology, particularly in the development of novel compounds and methods that have potential applications in medicine.

Latest Patents

Kyle A. Totaro holds 2 patents. His latest patents include "Syringolin analogues and methods of making and using same," which provides novel syringolin analogues that act as proteasome inhibitors. These compounds have the potential to treat or prevent cancers, such as leukemia, in subjects. Another notable patent is "Methods of chemoselective derivation of multiple classes of metabolites," which employs chemoselective derivatization of biological amines, carboxylic acids, aldehydes, or ketones. This method is designed to detect a variety of metabolites that differ in molecular structure and can be utilized in both aqueous and nonaqueous conditions.

Career Highlights

Kyle A. Totaro is affiliated with Brown University, where he continues to engage in innovative research and development. His work has contributed to advancements in the understanding and treatment of various medical conditions.

Collaborations

Kyle collaborates with notable colleagues, including Jason K. Sello and Babajide O. Okandeji. Their combined expertise enhances the research efforts and innovation at Brown University.

Conclusion

Kyle A. Totaro's contributions to the field of invention and innovation are noteworthy. His patents reflect a commitment to advancing medical science and improving treatment options for patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…